Important: This seminar has been converted to a ZOOM presentation. A link and directions to join the seminar will be emailed to registrants the week of the seminar.

Esketamine Therapy for Treatment-Resistant Depression (TRD)

Thursday, February 24, 2022  *  8:30 - 11:45 am (3 CEUs) 

(8:00 - 8:30 am: sign-in to Zoom wait room)

Register Now!

This program is funded in part by the William B. and Sylvia A. Hunsberger Fund

Research studies have shown that untreated depression adversely affects the brain and can cause long-term damage as well as increase the risk for cognitive impairment. Esketamine, a drug made from ketamine, has been approved by the FDA and proven to be effective for patients who do not respond to traditional antidepressant treatment. Dr. Adam Kaplin, founder and initial clinical director of the Johns Hopkins Psychiatric Esketamine Clinic, will discuss esketamine therapy and its potential to provide relief from treatment resistant major depression with or without acute suicidal ideation or behavior. Discussion will include: history and development, current research, mechanisms of action, risks and benefits of eskatimine therapy, how to assess patients for potential esketamine therapy, and future directions for es/ketamine treatment.

At the conclusion of the program, participants should be able to:

• Discuss antidepressants and how they work
• Define the epidemiology of treatment-resistant depression (TRD) and current treatment options
• Discuss current research into the mechanisms of action of ketamine for TRD
• Examine the risks, benefits and alternatives of ketamine treatment
• Identify patients who may be appropriate for referral for ketamine treatment

Featuring: Adam Kaplin, MD

Dr. Kaplin is a neuropsychiatrist in Baltimore, MD specializing in the treatment of individuals with central nervous system (CNS) neuroinflammatory diseases, such as multiple sclerosis (MS) and related MS spectrum disorders. Dr. Kaplin also treats individuals with other neuroinflammatory diseases with neuropsychiatric symptoms. He is the former principal psychiatric consultant to Johns Hopkins Multiple Sclerosis Center of Excellence and the founder and initial clinical director of the Johns Hopkins Psychiatric Esketamine Clinic. He performs both pre-clinical and clinical research on the biological basis of immune-mediated mood disorders and cognitive impairment with the goal of elucidating novel therapeutic strategies for neuroinflammatory and neurodegenerative disorders. Dr. Kaplin graduated magna cum laude from Yale University before earning his MD and PhD at Johns Hopkins, where he was a Medical Science Training Program awardee. Dr. Kaplin is currently adjunct faculty at Johns Hopkins University, having taken on being the CSO for MyMD Pharmaceuticals, a pharmaceutical company focusing on development of novel treatments for autoimmune diseases and neuropsychiatric illnesses, as well as for delaying aging.

Seminar Fee:  $79.00 (includes 3 CEUs)

CANCELLATION POLICY: A $10 processing fee will apply for all cancellations. To receive a refund, cancellations must be made in writing and received no later than one week prior to the seminar. No refunds/credits will be made after the one-week date or for no shows on the day of the program.

Continuing Education Information:

An important message about CEUs:  Brook Lane seminars are approved for continuing education credits as an entire event.  PARTIAL CREDIT WILL NOT BE AWARDED.  To assure that you receive continuing education credit, you must be on time and complete the entire seminar.

Counselors/Therapists: Brook Lane Health Services has been approved by NBCC as an Approved Continuing Education Provider (ACEP TM) # 5452. Programs that do not qualify for NBCC credit are clearly identified.  Brook Lane solely is responsible for all aspects of the program. This program will provide 3 clock hours; partial credit will not be awarded.

Social Workers: Brook Lane Health Services is an approved sponsor of the Maryland Board of Social Work Examiners for continuing education credits for licensed social workers in Maryland.  This program will provide 3.0 credit hours of Category I continuing education; partial credit will not be awarded.   

Psychologists: The Maryland State Board of Examiners for Psychologists will accept continuing education hours provided by Brook Lane, an approved CE sponsor by the Maryland Board of Social Work Examiners.

Other Healthcare Professionals and Attendees: A certificate of completion noting the number of educational/contact hours will be provided for other disciplines to allow attendees to apply for CE credit as an individual.